Teriparatide vs P-15

Head-to-head comparison of Teriparatide (Parathyroid Hormone (1-34)) and P-15 (Synthetic Collagen Type I Cell-Binding Peptide (P-15)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyTeriparatideP-15
CategoryRecovery & HealingRecovery & Healing
Full NameParathyroid Hormone (1-34)Synthetic Collagen Type I Cell-Binding Peptide (P-15)
Molecular Weight4117 Da1500 Da
Half-Lifeabout 1 hourN/A
Amino Acids3415
Typical Dose20 mcg dailydevice-dependent local loading
RouteSubcutaneousLocal/Implant
Purity≥98%≥98%
Studies Count1200150
Research StatusClinicalClinical

Teriparatide Benefits

  • stimulates bone formation
  • supports fracture union
  • improves bone mineral density
  • may aid bone remodeling

P-15 Benefits

  • improves osteoblast attachment
  • supports scaffold osteointegration
  • enhances bone fill
  • may aid periodontal regeneration

Teriparatide Dosing

20 mcg subcutaneous daily|intermittent anabolic exposure|monitor calcium and vitamin D status

P-15 Dosing

embedded in scaffold or graft material|local application|single procedural exposure

Teriparatide Side Effects

  • hypercalcemia
  • nausea
  • dizziness

P-15 Side Effects

  • local irritation
  • inflammation
  • hypersensitivity

Research Overview

Teriparatide

Teriparatide has extensive clinical literature showing anabolic effects on bone and investigational use in delayed unions and nonunions. It is one of the best-studied peptide-based options for skeletal recovery.

P-15

P-15 is a real literature-backed peptide used to improve biomaterial performance in bone repair settings. Most of the evidence is device- or scaffold-based rather than as a free systemic peptide.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Teriparatide stacks with:

Vitamin D3CalciumCollagen peptides

P-15 stacks with:

HydroxyapatiteCollagen scaffoldTeriparatide
bone-healingfracture-repairosteoanabolicpeptidebone-graftcell-adhesionosteointegration